Myoglobin immunoassay based on metal particle-enhanced fluorescence.

Enhanced fluorescence on silver island films (SIFs) is utilized to develop a sandwich-format immunoassay for the cardiac marker myoglobin (Myo). Myoglobin was first captured on surfaces coated with anti-Myo antibodies; the surface was then incubated with fluorescently labeled anti-Myo antibodies. The system was examined on glass surfaces and on SIFs. We observed the enhancement of the signal from SIFs in the range of 10-15-fold if compared to the signal from the glass substrate not modified with a SIF. A kinetic immunoassay for Myo on SIF-modified surface results in a decreased background signal. The initial results show that it is possible to detect Myoglobin concentrations below 50 ng/mL, which is lower than clinical cut-off for Myoglobin in healthy patients. We suggest the use of SIF-modified substrates for increasing the sensitivity of surface assays with fluorescence detection.

[1]  M. Panteghini.  The measurement of cardiac markers: where should we focus? , 2002, American journal of clinical pathology.

[2]  James McCord,et al.  Ninety-Minute Exclusion of Acute Myocardial Infarction By Use of Quantitative Point-of-Care Testing of Myoglobin and Troponin I , 2001, Circulation.

[3]  P. Trerotoli,et al.  Appropriateness of point-of-care testing (POCT) in an emergency department. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[4]  R. Fitzgerald,et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. , 2001, The American journal of cardiology.

[5]  James P. Egan,et al.  Signal detection theory and ROC analysis , 1975 .

[6]  W. Weaver,et al.  The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. , 2003, Annals of emergency medicine.

[7]  J. Mccabe,et al.  Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? , 1995, American journal of clinical pathology.

[8]  P. Collinson,et al.  Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. , 2000, Clinical chemistry.

[9]  W. Gibler,et al.  The role of cardiac markers in the emergency department. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[10]  R. D. de Winter,et al.  Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction. , 1996, Heart.

[11]  T. Kircher,et al.  Myoglobin in the early evaluation of acute chest pain. , 1995, American journal of clinical pathology.

[12]  W. Gibler,et al.  Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. , 2003, Reviews in cardiovascular medicine.

[13]  T Groth,et al.  Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis. , 1997, Clinical chemistry.

[14]  Galen Rs.  The normal range: a concept in transition. , 1977, Archives of pathology & laboratory medicine.

[15]  Zygmunt Gryczynski,et al.  Metal-enhanced fluorescence immunoassays using total internal reflection and silver island-coated surfaces. , 2004, Analytical biochemistry.

[16]  M Zaninotto,et al.  Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. , 1999, American journal of clinical pathology.

[17]  J. Alpert,et al.  Diagnosis of Myocardial Injury by Biochemical Markers: Problems and Promises , 2002, Cardiology in review.

[18]  Henderson Ar,et al.  AN OVERVIEW AND RANKING OF BIOCHEMICAL MARKERS OF CARDIAC DISEASE STRENGTHS AND LIMITATIONS , 1997 .

[19]  R H Christenson,et al.  Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. , 1999, Clinical chemistry.

[20]  I. Menown,et al.  Diagnosis and risk stratification of patients with anginal pain and non-diagnostic electrocardiograms. , 1999, QJM : monthly journal of the Association of Physicians.

[21]  A. Wu,et al.  Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM). , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[22]  P. Steg,et al.  A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. , 1995, Circulation.

[23]  G. Chumanov,et al.  Size-Controlled Synthesis of Nanoparticles. 1. “Silver-Only” Aqueous Suspensions via Hydrogen Reduction , 2004 .

[24]  A. Castaldo,et al.  Plasma Myoglobin in the Early Diagnosis of Acute Myocardial Infarction , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[25]  Michael Wirth,et al.  Silver nanoparticle enhanced immunoassays: one step real time kinetic assay for insulin in serum. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  A. Jaffe,et al.  Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study , 2001 .

[27]  Encai Hao,et al.  Synthesis and Optical Properties of Anisotropic Metal Nanoparticles , 2004, Journal of Fluorescence.

[28]  J. Lakowicz.  Radiative decay engineering: biophysical and biomedical applications. , 2001, Analytical biochemistry.

[29]  G. Hillis,et al.  Utility of cardiac troponin I, creatine kinase-MBmass, myosin light chain 1, and myoglobin in the early in-hospital triage of “high risk” patients with chest pain , 1999, Heart.

[30]  Improved identification of acute coronary syndromes with delta cardiac serum marker measurements during the emergency department evaluation of chest pain patients , 2007, Cardiovascular Toxicology.